Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial.
- Resource Type
- Article
- Source
- Diabetes Therapy; Jun2014, Vol. 5 Issue 1, p267-283, 17p
- Subject
- Language
- ISSN
- 18696953